Pro-life advocates urge inquiry into NIH-funded human fetal tissue research after agency spending declined

Pro-life advocates are calling for an investigation into National Institutes of Health-funded research that uses human fetal tissue, according to reporting Tuesday. The groups cited agency figures showing NIH spending on human fetal tissue research declined from nearly $120 million in fiscal year 2018 to about half that amount in fiscal year 2024.

The advocacy effort centers on the use of organs, tissues, and cells derived from human fetal sources in federally funded research. The New York Post reported that the groups are seeking scrutiny of how the NIH funds and oversees such studies, and whether current practices meet statutory and regulatory requirements.

NIH spending changes, as described in the report, have become part of the controversy over oversight and compliance. In the account, NIH funding for the category tracked by advocates dropped over the six-year period, including a shift from the near-$120 million level in fiscal year 2018 to approximately half that amount by fiscal year 2024.

Advocates’ arguments, as characterized in the report, focus on the source and handling of fetal tissue and the policy controls governing its use in research. They are seeking what they describe as an investigation into the NIH’s approach, despite the reported reduction in spending over time.

The request is part of a broader policy debate over the federal role in research involving fetal tissue, including questions about licensing, procurement, ethics oversight, and the documentation required for federally funded projects. The report frames the current dispute around whether NIH oversight has been adequate as agency funding levels change.

The NIH and other federal officials were not quoted in the provided packet beyond the reported funding trend, and no court filings or formal agency actions were included in the available material. As a result, it is not possible to confirm from the provided record whether an investigation has been opened, by whom, or on what specific legal or administrative authority.

Next steps, based on the reporting, depend on whether lawmakers or oversight bodies choose to act on the advocacy demands, and whether NIH provides additional documentation on how it funds and monitors human fetal tissue research. Any inquiry would likely turn on compliance records tied to specific grants and institutional review processes.